Velcade

Active Ingredient(s): Bortezomib
FDA Approved: * May 13, 2003
Pharm Company: * MILLENNIUM PHARMS
Category: Cancer

Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma.[1] This includes multiple myeloma in those who have and have not previously received treatment.[2] It is generally used together with other medications.[2] It is given by injection.[1] Common side effects include nausea, diarrhea, tiredness, low platelets, fever, numbness, low white blo... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Velcade 3.5 mg/1 Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution

NDC: 63020-049

Labeler:

Millennium Pharmaceuticals, Inc.

Dosage List

Popular Topics